{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:13:02Z","timestamp":1791475982460,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Polymorphisms in thiopurine methyltransferase (TPMT) and Nudix hydrolase-15 (NUDT15) have been implicated as the predominant cause of thiopurine induced leukopenia in the Western countries and East Asia respectively. Exact role of these polymorphisms in South Asian population with inflammatory bowel disease (IBD) is uncertain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included consecutive patients with IBD who were initiated on thiopurines at a center in North India. The dosage of thiopurines was titrated using regular monitoring of hemogram and liver function tests. Three TPMT polymorphisms (c.238 G\u2009&gt;\u2009C, c.460 G\u2009&gt;\u2009A, and c.719A\u2009&gt;\u2009G) and one NUDT15 polymorphism (c.415 C\u2009&gt;\u2009T) were assessed. Comparison regarding incidence of leukopenia and maximum tolerated thiopurine dosage was performed between those with wild polymorphism and those with TPMT and NUDT15 polymorphisms, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 119 patients (61 males, mean age 36.8\u2009\u00b1\u200913.5\u00a0years), 105 (88.2%) had ulcerative colitis and 14 (11.8%) had Crohn\u2019s disease. Leukopenia was noted in 33 (27.7%), gastrointestinal intolerance in 5 (4.2%) and pancreatitis in 2 (1.6%). TPMT polymorphisms were detected amongst five patients of whom 1 developed leukopenia. NUDT15 polymorphism was noted in 13 patients of whom 7 had leukopenia. The odds of developing leukopenia in TPMT polymorphism were non-significant (0.77, 95% CI:0.0822 to 7.2134,<jats:italic>P<\/jats:italic>\u2009=\u20090.819) but were significantly higher in those with NUDT15 polymorphism (3.5933, 1.1041 to 11.6951, P value:\u2009=\u20090.0336).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NUDT15 polymorphism was more frequent than TPMT polymorphisms and was associated with thiopurine induced leukopenia. However, the tested polymorphisms account for only 24.2% of the risk of thiopurine induced leukopenia.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12876-021-01900-8","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T14:05:14Z","timestamp":1629727514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India"],"prefix":"10.1186","volume":"21","author":[{"given":"Narinder","family":"Grover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antriksh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepesh","family":"Lad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal S.","family":"Mandavdhare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanta","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushal K.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2472-3409","authenticated-orcid":false,"given":"Vishal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"issue":"10","key":"1900_CR1","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.dld.2008.03.016","volume":"40","author":"S Saibeni","year":"2008","unstructured":"Saibeni S, Virgilio T, D\u2019Inc\u00e0 R, Spina L, Bortoli A, Paccagnella M, et al. The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice. Dig Liver Dis. 2008;40(10):814\u201320.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"1900_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/gut.50.4.485","volume":"50","author":"AG Fraser","year":"2002","unstructured":"Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut. 2002;50(4):485\u20139.","journal-title":"Gut"},{"issue":"7","key":"1900_CR3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/apt.16039","volume":"52","author":"A Vasudevan","year":"2020","unstructured":"Vasudevan A, Parthasarathy N, Con D, Nicolaides S, Apostolov R, et al. Thiopurines vs methotrexate: comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther. 2020;52(7):1174\u201384.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1900_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5217\/ir.2020.00002","volume":"18","author":"K Matsuoka","year":"2020","unstructured":"Matsuoka K. NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease. Intest Res. 2020;18(3):275\u201381.","journal-title":"Intest Res"},{"issue":"6","key":"1900_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40291-016-0232-1","volume":"20","author":"ML Seinen","year":"2016","unstructured":"Seinen ML, van Nieuw Amerongen GP, de Boer NK, van Bodegraven AA. Rac attack: modulation of the small GTPase rac in inflammatory bowel disease and thiopurine therapy. Mol Diagn Ther. 2016;20(6):551\u20137.","journal-title":"Mol Diagn Ther"},{"issue":"4900","key":"1900_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1126\/science.2649979","volume":"244","author":"GB Elion","year":"1989","unstructured":"Elion GB. The purine path to chemotherapy. Science. 1989;244(4900):41\u20137.","journal-title":"Science"},{"issue":"5","key":"1900_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/apt.15403","volume":"50","author":"S van Gennep","year":"2019","unstructured":"van Gennep S, Kont\u00e9 K, Meijer B, Heymans MW, D\u2019Haens GR, L\u00f6wenberg M, de Boer NKH. Systematic review with meta-analysis: risk factors for thiopurine-induced leukopenia in IBD. Aliment Pharmacol Ther. 2019;50(5):484\u2013506.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"1900_CR8","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1365-2036.2010.04287.x","volume":"31","author":"EJ van Geenen","year":"2010","unstructured":"van Geenen EJ, de Boer NK, Stassen P, et al. Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon. Aliment Pharmacol Ther. 2010;31(12):1322\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1\u20132","key":"1900_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/03602538508991433","volume":"16","author":"KG Van Scoik","year":"1985","unstructured":"Van Scoik KG, Johnson CA, Porter WR. The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathioprine. Drug Metab Rev. 1985;16(1\u20132):157\u201374.","journal-title":"Drug Metab Rev"},{"key":"1900_CR10","doi-asserted-by":"crossref","unstructured":"Nguyen CM, Mendes MA, Ma JD. Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.\u00a0PLoS Curr. 2011;3:RRN1236.","DOI":"10.1371\/currents.RRN1236"},{"key":"1900_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.leukres.2017.09.012","volume":"62","author":"M Singh","year":"2017","unstructured":"Singh M, Bhatia P, Khera S, Trehan A. Emerging role of NUDT15 polymorphisms in 6-mercaptopurine metabolism and dose related toxicity in acute lymphoblastic leukaemia. Leuk Res. 2017;62:17\u201322.","journal-title":"Leuk Res"},{"issue":"2","key":"1900_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00535-017-1416-0","volume":"53","author":"Y Kakuta","year":"2018","unstructured":"Kakuta Y, Kinouchi Y, Shimosegawa T. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping. J Gastroenterol. 2018;53(2):172\u201380. https:\/\/doi.org\/10.1007\/s00535-017-1416-0.","journal-title":"J Gastroenterol"},{"issue":"8","key":"1900_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.7326\/0003-4819-126-8-199704150-00003","volume":"126","author":"CR Yates","year":"1997","unstructured":"Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med. 1997;126(8):608\u201314.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1900_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00280-018-3732-3","volume":"83","author":"S Khera","year":"2019","unstructured":"Khera S, Trehan A, Bhatia P, Singh M, Bansal D, Varma N. Prevalence of TPMT, ITPA & NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with Acute Lymphoblastic Leukemia. Cancer Chemother Pharmacol. 2019;83(2):341\u20138.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1900_CR15","doi-asserted-by":"crossref","unstructured":"Walker GJ, Harrison JW, Heap GA, Voskuil MD, Andersen V, Anderson CA, et al; IBD Pharmacogenetics Study Group. Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease. JAMA. 2019;321(8):773\u201385.","DOI":"10.1001\/jama.2019.0709"},{"key":"1900_CR16","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.3748\/wjg.v20.i12.3327","volume":"20","author":"ATP Carvalho","year":"2014","unstructured":"Carvalho ATP, Esberard BC, Fr\u00f3es RSB, Rapozo DC, Grinman AB, Sim\u00e3o TA, et al. Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients. World J Gastroenterol. 2014;20:3327\u201334.","journal-title":"World J Gastroenterol"},{"key":"1900_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1046\/j.1365-2036.2003.01403.x","volume":"17","author":"LO Reuther","year":"2003","unstructured":"Reuther LO, Sonne J, Larsen N, Dahlerup JF, Thomsen OO, Schmiegelow K. Thiopurine methyltransferase genotype distribution in patients with Crohn\u2019s disease. Aliment Pharmacol Ther. 2003;17:65\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"1900_CR18","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.cgh.2019.08.034","volume":"18","author":"JY Chang","year":"2020","unstructured":"Chang JY, Park SJ, Jung ES, Jung SA, Moon CM, Chun J, Park JJ, Kim ES, Park Y, Kim TI, Kim WH, Cheon JH. Genotype-based Treatment With Thiopurine Reduces Incidence of Myelosuppression in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020;18(9):2010\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1900_CR19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/jgh.13494","volume":"32","author":"SA Shah","year":"2017","unstructured":"Shah SA, Paradkar M, Desai D, Ashavaid TF. Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients. J Gastroenterol Hepatol. 2017;32(3):620\u20134.","journal-title":"J Gastroenterol Hepatol"},{"issue":"11\u201312","key":"1900_CR20","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/apt.16137","volume":"52","author":"R Banerjee","year":"2020","unstructured":"Banerjee R, Ravikanth VV, Pal P, Bale G, Avanthi US, Goren I, Girish BG, Mitnala S, Reddy DN. NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine-induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India. Aliment Pharmacol Ther. 2020;52(11\u201312):1683\u201394.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"1900_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/17512433.2021.1900729","volume":"14","author":"A Jena","year":"2021","unstructured":"Jena A, Jha DK, Kumar-M P, Kasudhan KS, Kumar A, Sarwal D, Mishra S, Singh AK, Bhatia P, Patil A, Sharma V. Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis. Expert Rev Clin Pharmacol. 2021;14(4):491\u2013501.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1900_CR22","doi-asserted-by":"publisher","DOI":"10.1515\/dmdi-2021-0120","author":"A Yadav","year":"2021","unstructured":"Yadav A, Jena A, Thakur R, Kumar P, Bhatia P, Sharma V. Fatal thiopurine toxicity: pre-emptive testing of NUDT15 415C>T polymorphism may be life saving in South Asian population. Drug Metab Pers Ther. 2021. https:\/\/doi.org\/10.1515\/dmdi-2021-0120.","journal-title":"Drug Metab Pers Ther"},{"key":"1900_CR23","doi-asserted-by":"publisher","DOI":"10.1515\/dmpt-2020-0128","author":"AJ Devasia","year":"2020","unstructured":"Devasia AJ, Illangeswaran RSS, Raj IX, George B, Balasubramanian P. NUDT15 polymorphism explains serious toxicity to azathioprine in Indian patients with chronic immune thrombocytopenia and autoimmune hemolytic anemia: a case series. Drug Metab Pers Ther. 2020. https:\/\/doi.org\/10.1515\/dmpt-2020-0128.","journal-title":"Drug Metab Pers Ther"},{"key":"1900_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1856656","author":"S Mishra","year":"2020","unstructured":"Mishra S, Mandavdhare HS, Singh H, Choudhury A, Shah J, Ram S, Kalsi D, Samanta J, Prasad KK, Sharma AK, Dutta U, Sharma V. Adjuvant use of combination of antibiotics in acute severe ulcerative colitis: A placebo controlled randomized trial. Expert Rev Anti Infect Ther. 2020. https:\/\/doi.org\/10.1080\/14787210.2021.1856656.","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-021-01900-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T19:06:07Z","timestamp":1699383967000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-021-01900-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1900"],"URL":"https:\/\/doi.org\/10.1186\/s12876-021-01900-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The approval of the Institute Ethics committee was obtained prior to initiating this work. All patients were included after written informed consent by them or their representative.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"327"}}